Immune responses of microglia in the spinal cord: Contribution to pain states

Experimental Neurology

Volumn 234, Issue 2, 2012, Pages 262-270

  Schomberg, Dominic ^a   Olson, Julie K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cytokines; Immune response; Microglia; Neuropathic pain; Spinal cord

Indexed keywords

B7 ANTIGEN; BRAIN DERIVED NEUROTROPHIC FACTOR; CATHEPSIN S; CD40 LIGAND; CD86 ANTIGEN; FRACTALKINE; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y12 RECEPTOR; TOLL LIKE RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLODYNIA; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE SEVERITY; GENE EXPRESSION PROFILING; GLIA CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INNATE IMMUNITY; MICROGLIA; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; UPREGULATION;

ANIMALS; CHRONIC PAIN; MICROGLIA; NEURALGIA; NOCICEPTORS; PHAGOCYTOSIS; SPINAL CORD;

EID: 84858158112     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.021     Document Type: Review

References (136)

1. Aldieri E., Atragene D., Bergandi L., Riganti C., Costamagna C., Bosia A., Ghigo D. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation. FEBS Lett. 2003, 552:141-144.
2. Amantea D., Corasaniti M.T., Mercuri N.B., Bernardi G., Bagetta G. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion. Neuroscience 2008, 152:8-17.
3. Arai S., Harada N., Kubo N., Shen J., Nakamura A., Ikeda H., Tsuji H., Yamashita T. Induction of inducible nitric oxide synthase and apoptosis by LPS and TNF-alpha in nasal microvascular endothelial cells. Acta Otolaryngol. 2008, 128:78-85.
4. Barclay J., Clark A.K., Ganju P., Gentry C., Patel S., Wotherspoon G., Buxton F., Song C., Ullah J., Winter J., Fox A., Bevan S., Malcangio M. Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain 2007, 130:225-234.
5. Barres B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60:430-440.
6. Basbaum A.I. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med. 1999, 24:59-67.
7. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
8. Boivie J. On central pain and central pain mechanisms. Pain 1989, 38:121-122.
9. Brannan C.A., Roberts M.R. Resident microglia from adult mice are refractory to nitric oxide-inducing stimuli due to impaired NOS2 gene expression. Glia 2004, 48:120-131.
10. Brewer K.L., Nolan T.A. Spinal and supraspinal changes in tumor necrosis factor-alpha expression following excitotoxic spinal cord injury. J. Mol. Neurosci. 2007, 31:13-21.
11. Buchanan J.B., Sparkman N.L., Chen J., Johnson R.W. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 2008, 33:755-765.
12. Chan A., Magnus T., Gold R. Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system. Glia 2001, 33:87-95.
13. Chatzipanteli K., Garcia R., Marcillo A.E., Loor K.E., Kraydieh S., Dietrich W.D. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment. J. Neurotrauma. 2002, 19:639-651.
14. Choi E.M., Lee Y.S. Luteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982. Food Chem. Toxicol. 2010, 48:2607-2611.
15. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., Bevan S., Malcangio M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10655-10660.
16. Conde J.R., Streit W.J. Effect of aging on the microglial response to peripheral nerve injury. Neurobiol. Aging 2006, 27:1451-1461.
17. Conti A., Miscusi M., Cardali S., Germano A., Suzuki H., Cuzzocrea S., Tomasello F. Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 2007, 54:205-218.
18. Correale J., Villa A. The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 2004, 251:1304-1316.
19. Cortright D.N., Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 2004, 271:1814-1819.
20. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 2001, 429:161-176.
21. Cramer S.W., Baggott C., Cain J., Tilghman J., Allcock B., Miranpuri G., Rajpal S., Sun D., Resnick D. The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury. Mol. Pain 2008, 4:36.
22. Damjanac M., Rioux Bilan A., Barrier L., Pontcharraud R., Anne C., Hugon J., Page G. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Res. 2007, 1128:40-49.
23. del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Berg G.I., Koziol J.A. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:646-651.
24. Detloff M.R., Fisher L.C., McGaughy V., Longbrake E.E., Popovich P.G., Basso D.M. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 2008, 212:337-347.
25. Devor M. Sodium channels and mechanisms of neuropathic pain. J. Pain 2006, 7:S3-S12.
26. Ding Y.H., Li J., Rafols J.A., Ding Y. Reduced brain edema and matrix metalloproteinase (MMP) expression by pre-reperfusion infusion into ischemic territory in rat. Neurosci. Lett. 2004, 372:35-39.
27. DomBourian M.G., Turner N.A., Gerovac T.A., Vemuganti R., Miranpuri G.S., Tureyen K., Satriotomo I., Miletic V., Resnick D.K. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine (Phila Pa 1976) 2006, 31:2778-2782.
28. Ehde D.M., Osborne T.L., Jensen M.P. Chronic pain in persons with multiple sclerosis. Phys. Med. Rehabil. Clin. N. Am. 2005, 16:503-512.
29. Ehrhart J., Obregon D., Mori T., Hou H., Sun N., Bai Y., Klein T., Fernandez F., Tan J., Shytle R.D. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J. Neuroinflammation 2005, 2:29.
30. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10584-10589.
31. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
32. Ford A.L., Goodsall A.L., Hickey W.F., Sedgwick J.D. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 1995, 154:4309-4321.
33. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 1994, 25:227-233.
34. Gradl G., Gaida S., Gierer P., Mittlmeier T., Vollmar B. In vivo evidence for apoptosis, but not inflammation in the hindlimb muscle of neuropathic rats. Pain 2004, 112:121-130.
35. Graeber M.B., Bise K., Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol. Appl. Neurobiol. 1994, 20:406-408.
36. Grant A., Amadesi S., Bunnett N.W. Protease-activated receptors: mechanisms by which proteases sensitize TRPV channels to induce neurogenic inflammation and pain 2007.
37. Guindon J., Hohmann A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol. 2008, 153:319-334.
38. Gustin S.M., Peck C.C., Wilcox S.L., Nash P.G., Murray G.M., Henderson L.A. Different pain, different brain: thalamic anatomy in neuropathic and non-neuropathic chronic pain syndromes. J. Neurosci. 2011, 31:5956-5964.
39. Hains B.C., Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26:4308-4317.
40. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
41. Hasbargen T., Ahmed M.M., Miranpuri G., Li L., Kahle K.T., Resnick D., Sun D. Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. Ann. N. Y. Acad. Sci. 2010, 1198:168-172.
42. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 2006, 9:1512-1519.
43. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115:1-20.
44. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
45. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol. Sci. 2006, 27(Suppl 1):S1-S7.
46. Hu P., Bembrick A.L., Keay K.A., McLachlan E.M. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav. Immun. 2007, 21:599-616.
47. Hulsebosch C.E. From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury. Curr. Pharm. Des. 2005, 11:1411-1420.
48. Hulsebosch C.E. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol. 2008, 214:6-9.
49. Ibrahim M.M., Deng H., Zvonok A., Cockayne D.A., Kwan J., Mata H.P., Vanderah T.W., Lai J., Porreca F., Makriyannis A., Malan T.P. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10529-10533.
50. Ifuku M., Farber K., Okuno Y., Yamakawa Y., Miyamoto T., Nolte C., Merrino V.F., Kita S., Iwamoto T., Komuro I., Wang B., Cheung G., Ishikawa E., Ooboshi H., Bader M., Wada K., Kettenmann H., Noda M. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J. Neurosci. 2007, 27:13065-13073.
51. Imai Y., Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002, 40:164-174.
52. Inoue K., Tsuda M., Koizumi S. ATP receptors in pain sensation: Involvement of spinal microglia and P2X(4) receptors. Purinergic Signal 2005, 1:95-100.
53. Jin S.X., Zhuang Z.Y., Woolf C.J., Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 2003, 23:4017-4022.
54. Jo S., Bean B.P. Inhibition of neuronal voltage-gated sodium channels by brilliant blue G. Mol. Pharmacol. 2011, 80:247-257.
55. Katsura H., Obata K., Mizushima T., Sakurai J., Kobayashi K., Yamanaka H., Dai Y., Fukuoka T., Sakagami M., Noguchi K. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J. Neurosci. 2006, 26:8680-8690.
56. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 2008, 14:331-336.
57. Kim Y.J., Hwang S.Y., Oh E.S., Oh S., Han I.O. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J. Neurosci. Res. 2006, 84:1037-1046.
58. Kobayashi K., Yamanaka H., Fukuoka T., Dai Y., Obata K., Noguchi K. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 2008, 28:2892-2902.
59. Kondo S., Kohsaka S., Okabe S. Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo. Mol. Brain 2011, 4:27.
60. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
61. Kunori S., Matsumura S., Okuda-Ashitaka E., Katano T., Audoly L.P., Urade Y., Ito S. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia 2011, 59:208-218.
62. Lee Y.B., Schrader J.W., Kim S.U. p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 2000, 12:874-880.
63. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J. Neurosci. 2008, 28:5321-5330.
64. Lindia J.A., McGowan E., Jochnowitz N., Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J. Pain 2005, 6:434-438.
65. Liu Y., Kintner D.B., Chanana V., Algharabli J., Chen X., Gao Y., Chen J., Ferrazzano P., Olson J.K., Sun D. Activation of microglia depends on Na+/H+ exchange-mediated H+ homeostasis. J. Neurosci. 2010, 30:15210-15220.
66. Lu K., Cho C.L., Liang C.L., Chen S.D., Liliang P.C., Wang S.Y., Chen H.J. Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats. J. Thorac. Cardiovasc. Surg. 2007, 133:934-941.
67. Lv M., Liu Y., Zhang J., Sun L., Liu Z., Zhang S., Wang B., Su D., Su Z. Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury. Neuroscience 2011, 176:162-172.
68. Magnus T., Chan A., Grauer O., Toyka K.V., Gold R. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 2001, 167:5004-5010.
69. Marchand F., Perretti M., McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 2005, 6:521-532.
70. McGeer P.L., Schwab C., Parent A., Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann. Neurol. 2003, 54:599-604.
71. Mika J., Rojewska E., Makuch W., Przewlocka B. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience 2010, 165:1420-1428.
72. Minghetti L., Ajmone-Cat M.A., De Berardinis M.A., De Simone R. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res. Brain Res. Rev. 2005, 48:251-256.
73. Munch G., Gasic-Milenkovic J., Dukic-Stefanovic S., Kuhla B., Heinrich K., Riederer P., Huttunen H.J., Founds H., Sajithlal G. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp. Brain Res. 2003, 150:1-8.
74. Narantuya D., Nagai A., Sheikh A.M., Masuda J., Kobayashi S., Yamaguchi S., Kim S.U. Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One 2010, 5:e11746.
75. Nie H., Zhang H., Weng H.R. Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats. Neuroscience 2010, 170:901-912.
76. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
77. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., Ifuku M., Kosai Y., Wang B., Nolte C., Aoki S., Kettenmann H., Wada K. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 2007, 101:397-410.
78. Noguchi K., Okubo M. Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biol. Pharm. Bull. 2011, 34:1163-1169.
79. Oaklander A.L. Mechanisms of pain and itch caused by herpes zoster (shingles). J. Pain 2008, 9:S10-S18.
80. Obata K., Katsura H., Mizushima T., Sakurai J., Kobayashi K., Yamanaka H., Dai Y., Fukuoka T., Noguchi K. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J. Neurochem. 2007, 102:1569-1584.
81. Obata K., Katsura H., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Akira S., Noguchi K. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J. Neurochem. 2008, 105:2249-2259.
82. Ogier C., Bernard A., Chollet A.M., T, L.E.D., Hanessian S., Charton G., Khrestchatisky M., Rivera S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 2006, 54:272-284.
83. Olson J.K. Immune response by microglia in the spinal cord. Ann. N. Y. Acad. Sci. 2010, 1198:271-278.
84. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
85. Panek R.B., Benveniste E.N. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. J. Immunol. 1995, 154:2846-2854.
86. Pezet S., McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 2006, 29:507-538.
87. Pineau I., Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 2007, 500:267-285.
88. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
89. Price T.J., Cervero F., Gold M.S., Hammond D.L., Prescott S.A. Chloride regulation in the pain pathway. Brain Res. Rev. 2009, 60:149-170.
90. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., Malan T.P. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 2003, 99:955-960.
91. Racz I., Nadal X., Alferink J., Banos J.E., Rehnelt J., Martin M., Pintado B., Gutierrez-Adan A., Sanguino E., Manzanares J., Zimmer A., Maldonado R. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J. Neurosci. 2008, 28:12125-12135.
92. Rezaie P., Trillo-Pazos G., Greenwood J., Everall I.P., Male D.K. Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis. Exp. Cell Res. 2002, 274:68-82.
93. Ringshausen I., Dechow T., Schneller F., Weick K., Oelsner M., Peschel C., Decker T. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia 2004, 18:1964-1970.
94. Sappington R.M., Calkins D.J. Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. Invest. Ophthalmol. Vis. Sci. 2008, 49:3004-3017.
95. Sato J., Perl E.R. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991, 251:1608-1610.
96. Schafers M., Svensson C.I., Sommer C., Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 2003, 23:2517-2521.
97. Schipke C.G., Boucsein C., Ohlemeyer C., Kirchhoff F., Kettenmann H. Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J. 2002, 16:255-257.
98. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
99. Schwab J.M., Schluesener H.J. Microglia rules: insights into microglial-neuronal signaling. Cell Death Differ. 2004, 11:1245-1246.
100. Sharma H.S. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des. 2005, 11:1353-1389.
101. Sharma H.S., Badgaiyan R.D., Alm P., Mohanty S., Wiklund L. Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. Ann. N. Y. Acad. Sci. 2005, 1053:422-434.
102. Shrikant P., Benveniste E.N. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 1996, 157:1819-1822.
103. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 1999, 270:25-28.
104. Stella N. Cannabinoid signaling in glial cells. Glia 2004, 48:267-277.
105. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009, 56(Suppl 1):244-253.
106. Streit W.J. Microglia and macrophages in the developing CNS. Neurotoxicology 2001, 22:619-624.
107. Streit W.J., Davis C.N., Harrison J.K. Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists. Curr. Alzheimer Res. 2005, 2:187-189.
108. Tian L., Rauvala H., Gahmberg C.G. Neuronal regulation of immune responses in the central nervous system. Trends Immunol. 2009, 30:91-99.
109. Toda S., Sakai A., Ikeda Y., Sakamoto A., Suzuki H. A local anesthetic, ropivacaine, suppresses activated microglia via a nerve growth factor-dependent mechanism and astrocytes via a nerve growth factor-independent mechanism in neuropathic pain. Mol. Pain 2011, 7:2.
110. Tofaris G.K., Patterson P.H., Jessen K.R., Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. 2002, 22:6696-6703.
111. Torebjork H.E., Lundberg L.E., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J. Physiol. 1992, 448:765-780.
112. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., Inoue K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 2008, 28:4949-4956.
113. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783.
114. Tsuda M., Tozaki-Saitoh H., Masuda T., Toyomitsu E., Tezuka T., Yamamoto T., Inoue K. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56:50-58.
115. Tsuda M., Masuda T., Kitano J., Shimoyama H., Tozaki-Saitoh H., Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:8032-8037.
116. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
117. van Beek E.M., Cochrane F., Barclay A.N., van den Berg T.K. Signal regulatory proteins in the immune system. J. Immunol. 2005, 175:7781-7787.
118. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 2004, 20:1150-1160.
119. Vranken J.H. Mechanisms and treatment of neuropathic pain. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9:71-78.
120. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 1994, 654:15-26.
121. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001, 24:450-455.
122. White F.A., Bhangoo S.K., Miller R.J. Chemokines: integrators of pain and inflammation. Nat. Rev. Drug Discov. 2005, 4:834-844.
123. Williams K., Ulvestad E., Waage A., Antel J.P., McLaurin J. Activation of adult human derived microglia by myelin phagocytosis in vitro. J. Neurosci. Res. 1994, 38:433-443.
124. Wolf G., Gabay E., Tal M., Yirmiya R., Shavit Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 2006, 120:315-324.
125. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., Song Y., Jenmalm M., Gorman D., McClanahan T., Liu M.R., Brown M.H., Sedgwick J.D., Phillips J.H., Barclay A.N. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 2003, 171:3034-3046.
126. Wynne A.M., Henry C.J., Huang Y., Cleland A., Godbout J.P. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 2010, 24:1190-1201.
127. Yang J.Y., Kim H.S., Lee J.K. Changes in nitric oxide synthase expression in young and adult rats after spinal cord injury. Spinal Cord 2007, 45:731-738.
128. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain 1996, 68:185-194.
129. Yu Y., Matsuyama Y., Nakashima S., Yanase M., Kiuchi K., Ishiguro N. Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Neuroreport 2004, 15:2103-2107.
130. Yune T.Y., Chang M.J., Kim S.J., Lee Y.B., Shin S.W., Rhim H., Kim Y.C., Shin M.L., Oh Y.J., Han C.T., Markelonis G.J., Oh T.H. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J. Neurotrauma 2003, 20:207-219.
131. Zhang Z., Trautmann K., Schluesener H.J. Microglia activation in rat spinal cord by systemic injection of TLR3 and TLR7/8 agonists. J. Neuroimmunol. 2005, 164:154-160.
132. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 2007, 27:12396-12406.
133. Zhang B., West E.J., Van K.C., Gurkoff G.G., Zhou J., Zhang X.M., Kozikowski A.P., Lyeth B.G. HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res. 2008, 1226:181-191.
134. Zhang M., Martin B.R., Adler M.W., Razdan R.K., Ganea D., Tuma R.F. Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury. Neuroscience 2008, 152:753-760.
135. Zhuang Z.Y., Gerner P., Woolf C.J., Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.
136. Zhuang Z.Y., Kawasaki Y., Tan P.H., Wen Y.R., Huang J., Ji R.R. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun. 2007, 21:642-651.